XTSXPINK
Market cap24mUSD
Dec 20, Last price
0.41CAD
1D
1.25%
1Q
-3.57%
Jan 2017
350.00%
Name
Perimeter Medical Imaging AI Inc
Chart & Performance
P/E
—
P/S
65.81
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
37.21%
Rev. gr., 5y
%
Revenues
404k
+203.94%
Net income
-19m
L+428.29%
CFO
-15m
L+23.83%
Earnings
Mar 26, 2025
Profile
Perimeter Medical Imaging AI, Inc., a medical technology company, develops and commercializes advanced imaging tools that allow surgeons, radiologists, and pathologists to visualize microscopic tissue structures during a clinical procedure. The company offers an optical coherence tomography (OCT) imaging system provides clinicians with cross-sectional of tissues down to 2 mm dept. This OCT imaging system consists of S-series OCT, B-series OCT, and OCT imaging console. It also offers ImgAssist, an artificial intelligence technology that enhances the efficiency of image review and be an additional powerful tool when combined with Perimeter OCT to aid physicians with real-time margin visualization and assessment to improve surgical outcomes for patients and reducing the likelihood of needing additional surgeries. In addition, the company offers proprietary image library and consumable specimen containers to hospitals and cancer surgery centers. Perimeter Medical Imaging AI, Inc. was founded in 2013 and is headquartered in Toronto, Canada.
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | |||||||||
Revenues | 404 203.94% | 133 1,070.47% | 11 | ||||||
Cost of revenue | 18,108 | 15,790 | 16,066 | ||||||
Unusual Expense (Income) | |||||||||
NOPBT | (17,705) | (15,658) | (16,055) | ||||||
NOPBT Margin | |||||||||
Operating Taxes | 2 | (6,320) | 110 | ||||||
Tax Rate | |||||||||
NOPAT | (17,705) | (9,338) | (16,165) | ||||||
Net income | (18,944) 428.29% | (3,586) -78.61% | (16,762) 109.45% | ||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | 38,137 | 10,260 | |||||||
BB yield | -38.36% | -5.67% | |||||||
| Debt | |||||||||
Debt current | 51 | 150 | 180 | ||||||
Long-term debt | 335 | 381 | 412 | ||||||
Deferred revenue | 96 | 272 | 154 | ||||||
Other long-term liabilities | |||||||||
Net debt | (18,048) | (27,908) | (4,550) | ||||||
| Cash flow | |||||||||
Cash from operating activities | (14,696) | (11,868) | (13,912) | ||||||
CAPEX | (475) | (1,991) | (2,122) | ||||||
Cash from investing activities | 206 | (1,749) | (1,448) | ||||||
Cash from financing activities | 234 | 40,284 | 10,055 | ||||||
FCF | (18,508) | (9,565) | (18,955) | ||||||
| Balance | |||||||||
Cash | 18,434 | 28,439 | 5,143 | ||||||
Long term investments | |||||||||
Excess cash | 18,414 | 28,432 | 5,142 | ||||||
Stockholders' equity | 7,094 | 19,468 | (1,411) | ||||||
Invested Capital | 13,135 | 7,236 | 9,430 | ||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | 64,671 | 60,616 | 44,110 | ||||||
Price | 1.22 -25.61% | 1.64 -60.00% | 4.10 54.72% | ||||||
Market cap | 78,899 -20.63% | 99,410 -45.03% | 180,850 150.68% | ||||||
EV | 60,850 | 71,502 | 176,300 | ||||||
EBITDA | (17,090) | (14,857) | (15,961) | ||||||
EV/EBITDA | |||||||||
Interest | 105 | 110 | |||||||
Interest/NOPBT | |||||||||